1. Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis

   • Ying Yan
   • Sylvi Silvennoinen-Kassinen
   • Pekka Saikku

   OriginalPaper 09 June 2010 Pages: 189 - 195

   

2. Neonatal Exendin-4 Leads to Protection from Reperfusion Injury and Reduced Rates of Oxidative Phosphorylation in the Adult Rat Heart

   • Suzanne B. Brown
   • Joseph R. Libonati
   • Rebecca A. Simmons

   OriginalPaper 26 June 2010 Pages: 197 - 205

   

3. Role of Dual Antiplatelet Therapy in Symptomatic Patients with Established Vascular Disease: Putting the CHARISMA Trial into Therapeutic Perspective

   • William E. Boden
   • Marcus D. Flather
   • Deepak L. Bhatt

   ReviewPaper 01 July 2010 Pages: 207 - 216

   

4. How to Mediate Cardioprotection in Ischemic Hearts—Accumulated Evidence of Basic Research Should Translate to Clinical Medicine

   • Masafumi Kitakaze

   OriginalPaper 14 July 2010 Pages: 217 - 223

   

5. Mechanism of Cardioprotection by Early Ischemic Preconditioning

   • Xiulan Yang
   • Michael V. Cohen
   • James M. Downey

   ReviewPaper 27 May 2010 Pages: 225 - 234

6. The Second Window of Preconditioning (SWOP) Where Are We Now?

   • Derek J. Hausenloy
   • Derek M. Yellon

   ReviewPaper 23 May 2010 Pages: 235 - 254

   

7. Mitochondria and GSK-3β in Cardioprotection Against Ischemia/Reperfusion Injury

   • Tetsuji Miura
   • Masaya Tanno

   ReviewPaper 20 May 2010 Pages: 255 - 263

8. Postconditioning in Reperfusion Injury: A Status Report

   • Zhi-Qing Zhao

   ReviewPaper 09 June 2010 Pages: 265 - 279

   

9. Cardioprotection in the Clinical Setting

   • Fabrice Ivanes
   • Nathan Mewton
   • Michel Ovize

   OriginalPaper 30 June 2010 Pages: 281 - 287

   

10. Cardioprotection in the Clinical Setting-Lessons from J-WIND Studies

    • Masanori Asakura
    • Masafumi Kitakaze

    OriginalPaper 06 August 2010 Pages: 289 - 295